:::

師資陣容

本所師資

郎慧珠照片

郎慧珠
Lang, Hui-Chu

辦公室：護理館5樓521室

聯絡電話：(02)2826-7015

傳真電話：(02)2823-7298

E-mail：hclang@nycu.edu.tw

學歷

美國約翰霍普金斯大學醫療管理博士

國立陽明大學公共衛生碩士

中國醫藥大學公共衛生學士


現職

國立陽明大學醫務管理研究所教授


經歷

國立陽明大學醫務管理研究所 副教授

國立陽明大學醫務管理研究所 助理教授

國立陽明大學醫務管理研究所 講師


研究興趣

成本效益評估

醫院績效管理


Pub Med之著作


代表著作
  1. Chiu CM, Chen MS, Lin CS, Lin WY, Lang HC*. Evaluating the comparative efficiency of medical centers in Taiwan: a dynamic data envelopment analysis application. BMC Health Serv Res. 2022 Apr 2;22(1):435. doi: 10.1186/s12913-022-07869-8.
  2. Chiou LJ, Lang HC*. Potentially preventable hospital readmissions after patients' first stroke in Taiwan. Sci Rep. 2022 Mar 8;12(1):3743. doi: 10.1038/s41598-022-07791-3. SCI/SSCI, IF= 4.38 / Q1 (19/128). MOST 105-2410-H-010 -012 -SS2.
  3. Yang CP, Li CY, Huang WJ, Yu HL, Yang CC, Lu MC, Lang HC*, Yan YH*. Short-, Mid-, and Long-Term Associations Between PM2.5 and Stroke Incidence in Taiwan. J Occup Environ Med. 2021 Sep 1;63(9):742-751. SCI/SSCI, IF=4.4 / Q1 (39/376). MOST 105-2410-H-010 -012 -SS2
  4. Yang CP, Cheng HM, Lu MC, Lang HC*. Association between continuity of care and long-term mortality in Taiwanese first-ever stroke survivors: An 8-year cohort study. PLoS One. 2019 May 22;14(5):e0216495. SCI/SSCI, IF=3.24 / Q1 (29/128). MOST 105-2410-H-010 -012 -SS2
  5. Cheng HM, Chiou LJ, Chen TC, Sung SH, Chen CH, Lang HC*. Real-world cost- effectiveness of drug-eluting stents vs. bare-metal stents for coronary heart disease-A five-year follow-up study. Health Policy. 2019 Feb;123(2):229-234. SCI/SSCI, IF=2.98 / Q2 (48/150). NSC 101-2410-H-010
  6. Lang HC, Chen HW, Chiou TJ, Chan AL. The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan. J Med Econ. 2016 Oct;19(10):923-7. SCI/SSCI, IF=2.45 / Q2 (63/150).
  7. Chang JY, Lang HC. The Econimic Cost of Rheumatoid Arthritis in Taiwan. Value Health. 2014 Nov;17(7):A773. doi: 10.1016/j.jval.2014.08.328. Epub 2014 Oct 26. SCI/SSCI, IF=5.73 / Q1 (51/557).
  8. Shih CL, Chen CH, Sheu CF, Lang HC*, Hsieh CL. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model. Value Health. 2013 Jul-Aug;16(5):848-54. doi: 10.1016/j.jval.2013.05.004. Epub 2013 Jul 17. PMID: 23947980. SCI/SSCI, IF=5.73 / Q1 (51/557).
  9. Lang HC, Chang K, Ying YH. Quality of life, treatments, and patients' willingness to pay for a complete remission of cervical cancer in Taiwan. Health Econ. 2012 Oct;21(10):1217-33. SCI/SSCI, IF=3.05 / Q1 (112/557).
  10. Lang HC*. Willingness to pay for lung cancer treatment. Value Health. 2010 Sep-Oct;13(6):743-9. SCI/SSCI, IF=5.73 / Q1 (51/557).
回本所師資
go top